Studies related to Lymphocyte Count and Lactobacillus reuteri

Safety And Tolerance Of Lactobacillus Reuteri Supplementation To A Population Infected With The Human Immunodeficiency Virus

Effect None
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 39
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Body Types Average
Notes for this study:
Supplementation of _l. reuteri_ at 10^10^ CFU in two divided doses a day for three weeks in persons with HIV failed to significantly influence any observed biochemical parameter to a level which was deemed practically relevant, with most parameters also failing to be significantly influenced.

Full details on all 2 studies are available to Examine Plus members.

Already a member? Login now to access.